Abstract Borderline personality disorder (BPD) is characterised by a deep-reaching pattern of affective instability, incoherent identity, self-injury, suicide attempts, and disturbed interpersonal relations and lifestyle. The daily activities of BPD patients are often chaotic and disorganized, with patients often staying up late while sleeping during the day. These behavioural patterns suggest that altered circadian rhythms may be associated with BPD. Furthermore, BPD patients frequently report suffering from sleep disturbances. In this review, we overview the evidence that circadian rhythms and sleep are disturbed in BPD, and we explore the possibility that personality traits that are pertinent for BPD may be associated with circadian typology, and perhaps to circadian genotypes. With regards to sleep architecture, we review the evidence that BPD patients display altered non-REM and REM sleep. A possible cue to a deeper understanding of this temporal dysregulation might be an analysis of the circadian clock at the molecular and cellular level, as well as behavioural studies using actigraphy and we suggest avenues for further exploration of these factors.
Introduction
Borderline personality disorder (BPD) is characterized by a deep-reaching pattern of affective instability, incoherent identity, self-injury, suicide attempts, and disturbed interpersonal relations and lifestyle (DSM-IV). The prevalence of BPD is approximately 1-2 % in the general population; BPD is more often diagnosed in women than in men and often co-occurs with Axis I disorders such as depression (96 %), anxiety disorders (64 %), posttraumatic stress disorder (65 %), substance abuse or substance dependency (64 %), ADHD (39 %), and eating disorders (53 %) (Bohus 2009 ). Interestingly, patients with BPD often report subjective sleep problems, especially insomnia, nightmares and dream anxiety (Bastien et al. 2008; Semiz et al. 2008) . Furthermore, it has been suggested that the disturbed sleeping behaviour may alter the regulation of emotion in these patients (Harty et al. 2010) , thus shaping the phenotype of the disorder.
Circadian rhythms, BPD and personality
The daily activities of BPD patients are often chaotic as well as disorganized, and the patients often stay up late while sleeping during the day (Cervena and Matousek 2005; Prasko et al. 2005) , suggesting abnormal circadian timekeeping. The term circadian rhythm denotes an endogenously driven, circa 24-h cycle in metabolic, endocrine and behavioural processes such as the sleepwake cycle, and circadian processes are often found to be disturbed in psychiatric and neurological conditions (Wulff et al. 2010) . Verkes et al. (1996) show that BPD, along with suicide ideation and impulsiveness, was associated with diminished circadian rhythmicity in activity as assessed by actigraphy. That the diurnal variation in mood may be more pronounced in BPD patients than in those with depression and healthy controls was suggested by the study of Cowdry et al. (1991) and this observation may be in line with recent insight into how the circadian system may impact on affect (Wirz-Justice 2006; Hampp et al. 2008; Golder and Macy 2011) . Analysis of the diurnal profile of salivary cortisol in female BPD patients reveals an elevated cortisol response to waking as well as a general upregulation of cortisol levels in BPD (Lieb et al. 2004 ). Further, the study of Wingenfeld et al. (2007) indicates that the level of nocturnal cortisol is associated with the severity of the BPD psychopathology. Given the key role for the circadian clock in determining the cortisol rhythm (Saper et al. 2005) , these results may further indicate altered circadian processes in BPD. High levels of personality disorders (including BPD) have also been reported in patients suffering from circadian rhythm sleep disorders, again suggesting a link between circadian function and BPD (Dagan et al. 1996; Dagan and Eisenstein 1999) . Further study is needed in order to better understand the nature of the circadian dysregulation that may accompany BPD, for example utilizing actigraphy which recently has been validated as an appropriate tool in BPD research (Huynh et al. 2010) . Further, assays of molecular and endocrine circadian markers in BPD should prove useful (Baird et al. 2011 ).
An important factor in allowing for a deeper understanding of temporal deregulation in BPD will be analysis of circadian clock genes and their protein products, molecular factors that underpin circadian function in mammals. Clock genes contribute to the interconnection between energy metabolism, immune function, behavioural state setting and circadian rhythmicity, and may provide a direct link between the circadian and homeostatic regulation of sleep (Franken and Dijk 2009) . Physiologically, circadian rhythmicity is generated by the interaction at a molecular level of endogenous clock genes such as CLOCK, BMAL1, PER1, PER2, and REV-ERB-a and intracellular mediators of external zeitgeber such as daylight. In mammals, the master circadian pacemaker is located in the suprachiasmatic nucleus (SCN) of the anterior hypothalamus with further semi-autonomous oscillators located throughout the brain and the periphery. Although there is evidence for abnormal circadian timekeeping and alterations of clock genes in several psychiatric populations (Wulff et al. 2010; Coogan and Thome 2011) there are-to our knowledge-no studies examining specifically polymorphisms in clock genes and/ or their expression pattern in BPD, and as noted above this is an area that warrants further exploration.
Another set of indications for associations of circadian processes with personality disorders is the associations between personality traits and diurnal preference (i.e. morningness vs. eveningness) and the possibility of a shared genetic component between these. Twin, adoption, and family studies have clearly established that personality traits have a genetic basis (Bouchard and Loehlin 2001) . The five-factor model of personality differentiates the personality traits ''neuroticism'', ''extraversion'', ''openness to experience'', ''agreeableness'', and ''conscientiousness'', and provides the basis to interpret personality disorders as maladaptive variants of continuously distributed personality traits (Distel and Trull 2009) . Clearly, ''agreeableness'' and ''conscientiousness'' are not identical. Furthermore ''agreeableness'' is not a trait of BPD. Terracciano et al. (2010) performed a genome-wide association scan in a genetically isolated population from Sardinia, in order to identify possible genetic variants associated with each of the five personality dimensions. Personality traits were assessed using the Revised NEO Personality Inventory (NEO-PI-R). The authors found an association between agreeableness and several single nucleotide polymorphisms (SNPs) within or close to the CLOCK gene (King et al. 1997) . Although effect sizes were small (less than 1 %), the association between agreeableness and CLOCK was demonstrated in two of three replication samples (King et al. 1997) . Kendler et al. (2011) found a positive correlation between pathological BPD traits as measured by the Dimensional Assessment of Personality Pathology Basic Questionnaire and the neuroticism score of the Big Five Inventory as well as a negative correlation with the conscientiousness and agreeableness scores. Further links between circadian phenotype and personality are obtained in the study of Hogben et al. (2007) which reports that conscientiousness is a predictor of chronotype, which itself is influenced by polymorphisms in clock genes such as the variable number tandem repeat in PER3 (Ellis et al. 2009 ). There are numerous other studies linking circadian typology with personality traits (e.g. Caci et al. 2004; Susman et al. 2007; Adan et al. 2010) . For example, and perhaps of particular reference to BPD is the recent report that using Zuckerman's Alternative five-factor personality model, a strongly biologically based paradigm, eveningness in women was associated with aggression-hostility and impulsiveness-sensation seeking (Muro et al. 2011 ). If chronotype is determined biologically via circadian genotype, then there may be a link from clock genes through chronotype onto personality features associated with BPD. Numerous studies that either have shown associations between clock gene polymorphisms and chronotype (Katzenberg et al. 1998; Archer et al. 2003; Johansson et al. 2003; Mishima et al. 2005) or have not (Barclay et al. 2011; Chang et al. 2011; Osland et al. 2011; Voinescu and Coogan 2012) . Therefore, given the limited empirical data to hand at present, it remains speculative whether there is a relationship between clock genes and BPD mediated via chronotype and personality traits.
Sleep disorder in patients with BPD
Sansone et al. (2009) performed a cross-sectional study to examine the relationship between subjective sleep quality and borderline personality symptoms among 76 internal medicine outpatients. In this study, the Pittsburgh Sleep Quality Index (PSQI) was used to measure subjective sleep quality, sleep duration, sleep latency and daytime dysfunction and the Borderline Personality Scale of the Personality Diagnostic Questionnaire-4 (PDQ-4) and the Self-Harm Inventory (SHI) were used in order to evaluate borderline personality symptomatology. Significant associations were found between all PSQI subscales and the PDQ-4, and between sleep latency and the SHI. These results suggest that individuals with more severe borderline personality symptoms have more difficulties with their sleep structure than people with less pronounced borderline personality symptoms. However, the relationship between both disorders is not yet well understood.
Beyond the examination of subjective sleep quality, several research groups have used electro-encephalography (EEG) in order to obtain objective measures of sleep performance. A number of publications focus on sleep disorder, BPD and EEG (Bell et al. 1983; McNamara et al. 1984; Benson et al. 1990; Battaglia et al. 1993 Battaglia et al. , 1999 De la Fuente et al. 2001 Asaad et al. 2002; Philipsen et al. 2005; Bastien et al. 2008 ). Bastien and colleagues (2008) looked at differences in sleep structure between BPD patients, insomnia patients (both paradoxical and psychophysiological), and healthy sleepers as control individuals. The participants of this study spent three nights in a sleep laboratory, where polysomnography recordings were conducted. The authors found that BPD subjects and insomnia subjects had longer sleep onset, shorter sleep time and lower sleep efficiency than controls. Furthermore, patients with BPD had more Non-REM stage 4 sleep than patients with paradoxical insomnia. In two other studies by Battaglia et al. (1993 Battaglia et al. ( , 1999 , BPD patients without any current co-morbid Axis I disorder were compared with healthy controls after continuous 48-h ambulatory electroencephalographic monitoring. The authors reported that REM density in subjects with BPD was significantly higher in the first REM period, and that REM latency was shorter, sleep latency and time spent awake after sleep onset were longer, while the number of awakings was higher compared to the control subjects. However, this finding was only partially replicated by Philipsen et al. (2005) who found that BPD patients without any current comorbid Axis I disorder displayed a tendency towards shortened REM latency and significantly decreased Non-REM stage 2 sleep in comparison to healthy controls. The spectral EEG analysis revealed increased delta power in total Non-REM sleep and in REM sleep in BPD subjects.
Due to the frequent co-morbidity between BPD and depression, several studies have focused on the association between BPD and depression using polysomnographic recording (Basset 2012; Huynh et al. 2012) . Bell et al. (1983) studied two sub-samples of patients with major depression (with and without comorbid BPD) for a period of three nights using EEG recording. Both groups displayed a similar pattern of abnormal shortened REM latency and sleep continuity disturbances. Covarying for the Hamilton depression rating score yielded a shorter REM latency in depressive patients with BPD when compared with non-BPD depressive patients. McNamara et al. (1984) examined the sleep behaviour of ten subjects with BPD, ten subjects with major depressive disorder (MDD) and ten healthy control subjects over two nights and reported similar findings for the BPD and MDD groups, i.e. mainly sleep continuity disturbances (lower asleep and sleep efficiency) as well as disturbances in sleep architecture (more stage 2 REM) and REM sleep (shorter REM latency; higher REM activity, density and intensity in the first REM period). Asaad et al. (2002) examined 20 patients with BPD, 20 with MDD, and 20 healthy controls. Both clinical groups differed from healthy controls with regard to longer sleep latency, lower sleep efficiency, lower stage 4 and slow wave sleep percentage, higher REM percentage, shorter REM latency, longer first REM period, and higher REM density. The MDD group differed from the BPD group with regard to longer sleep latency, lower sleep efficiency with higher arousal, shorter REM latency, higher REM density, lower first REM period, and higher REM density in the first REM period. Benson et al. (1990) examined 33 male individuals [18 with BPD with (n = 8) and without (n = 10) additional affective symptoms; 15 controls]. The whole BPD group exhibited lower waking after sleep onset, lower total sleep time, lower percent sleep and less stage 1 and stage 4 of total sleep when compared with controls. De la Fuente et al. (2001) examined 20 patients with BPD, 20 patients with MDD, and 20 healthy controls. They found that both individuals with BPD and those with MDD suffer from lower total sleep time and higher sleep onset latency, as well as higher percentage wakefulness when compared with controls. Furthermore, they found extended stage 2 sleep, lower stage 3 and 4 sleep, and higher REM sleep duration in BPD when compared with MDD.
Despite their methodological differences, all the mentioned studies on subjective and objective sleep measures reveal that sleep disturbances play a critical role in the pathophysiology of BPD. In summary, the sleep profile of BPD patients is significantly disturbed with regard to sleep continuity, at the same time Non-REM sleep stages as well as REM density and latency seem to be affected. Notably, the majority of studies revealed similar sleep patterns for patients with BPD and MDD, albeit less pronounced in BPD, especially with regard to shorter REM latency and higher REM density. However, the exact nature of the differences and similarities between BPD and MDD patients regarding sleep disturbances remains to be clarified. Given the literature describing circadian rhythm disturbance in MDD (Wirz-Justice 2006) and the potential for such rhythm disturbance to be a major predictor of sleep disturbance, it will be of prime importance to assess circadian function in BPD populations in parallel with the objective assessment of sleep.
Therapeutic implications
To our knowledge, no specific strategies have yet been established for the treatment of sleep disturbances in BPD. Similarly, the potential use of so-called chronotherapeutics in the treatment of BPD has not been sufficiently investigated. Plante et al. (2009) compared BPD patients' use of sedative-hypnotic medication with that of patients with other personality disorders. They found that BPD patients used a significantly higher percentage of both PRN and standing medications to help them sleep (Plante et al. 2009 ), demonstrating again the clinical relevance of sleep disturbances in BPD, and suggesting a high risk of drug abuse due to these disturbances. De la Fuente et al. (2002) found that carbamazepine (CBZ) increased slow wave sleep in the sleep EEG of BPD patients. CBZ was chosen because of its mood-stabilizing effect and its moderating effect on aggressive behaviour (Dalby 1975) . Although CBZ did not show clinical benefits in a previous study (de la Fuente and Lotstra 1994) , this finding indicates that CBZ affects objective biological sleep markers associated with sleep disturbances in BPD, although this does not imply a causal association. Interestingly, other mood stabilizers such as lithium (Yin et al. 2006 ) and sodium valproate (Johansson et al. 2011 ) have been shown to modify circadian rhythms, a factor that may be of interest in their use in BPD. Some studies have demonstrated antidepressant effects of phototherapy in subjects with non-seasonal depressive episodes. For example, Prasko et al. (2010) reported that a 6-week application of morning bright light therapy combined with administration of antidepressants could be an effective short-term augmentation strategy for BPD patients suffering from drug-resistant non-seasonal depressive episodes. This finding suggests that chronotherapeutic approaches may be useful in the management of BPD and indicate that further study to explore the use of light therapy and/or chronopharmaceutics (e.g. melatonin and agomelatine) is required.
Conclusion
There is some limited direct empirical evidence that circadian rhythms are altered in BPD, and that circadian rhythm sleep disorders are linked with BPD. Further there remains the putative link between clock genes, chronotype and personality domains that may be prescient for the understanding of novel aetioloigcal factors in BPD. Further, patients with BPD have subjective and objective sleep complaints compared to healthy controls and other clinical groups, with BPD subjects suffering from disturbed sleep physiology. The finding of disturbed EEG sleep patterns as objective measures in both BPD and MDD suggests that both conditions might share a common biological substrate. One could argue that BPD represents rather a ''trait marker'', whereas MDD rather a ''state marker'' of sleep disturbances (Steiner et al. 1988) . Again, further research is needed in order to understand the causality of sleep disturbances as well as chaotic and disorganized daily activities in subjects suffering from BPD. Future studies should address themselves to examine behavioural, molecular and endocrine markers of circadian function in BPD, as well as genetic association studies for clock gene polymorphisms in BPD, and examining the links between potentially altered circadian function and impaired sleep in BPD. Finally, as noted above, there may be clinical merit in the exploration of chronobiologically based intervention strategies in symptom relief in BPD. 
